SLNO 6-DAY DEADLINE ALERT: Hagens Berman Alerts Soleno Therapeutics (SLNO) Investors to Securities Class Action Alleging Hyperphagia Drug Launch Disruptions - Hagens Berman
Soleno Therapeutics(US:SLNO) TMX Newsfile·2026-04-30 02:39San Francisco, California--(Newsfile Corp. - April 29, 2026) - National shareholder rights law firm Hagens Berman reminds investors in Soleno Therapeutics, Inc. (NASDAQ: SLNO) of the pending securities class action and the upcoming May 5, 2026 lead plaintiff deadline. The firm urges investors who purchased Soleno common stock between March 26, 2025, and November 4, 2025 (the "Class Period"), and suffered significant losses to submit your losses now.Case Name: City of Pontiac Police &Fire Ret. Sys. v. Solen ...